Obrixtamig Antibody
Obrixtamig is a humanized bispecific antibody of the IgG1 subclass, engineered with kappa and lambda light chains, that specifically targets CD3e on T cells and HEK. It is utilized in preclinical research for investigating T-cell engagement and redirecting cytotoxicity in both in vitro cellular assays and in vivo oncology models.
Product Specifications
Target
Integrin
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
